Blog

Novartis Trying to Buy Israeli Stem Cell Research Developer – The Jewish Press

The Jewish Press
Gamida Cell has proprietary technology for growing the number and density of stem cells within a specific blood sample and seeks to enhance umbilical cord blood donations for implants to cure blood cancer in adults. Currently, umbilical cord blood can …
Novartis In Advanced Talks to Acquire Israeli Stem Cell Developer Gamida-CellJewish Business News
Gamida Cell Weighs Buyout; Novartis Mum on ReportGenetic Engineering News
Report: Novartis circles a deal to buy Gamida Cell in $600M dealFierceBiotech
Chicago Tribune (blog)
all 16 news articles

…read more    

2014-03-18 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.